The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Nebulizers and Inhalers-Global Market Insights and Sales Trends 2024
Synopsis
Inhalers and nebulizers are two different devices used to deliver quick-relief medicines (also called rescue or fast-acting medicines) or long-term control medicines (also called controller or maintenance medicines) directly into the lungs
The global Nebulizers and Inhalers market size is expected to reach US$ 18040 million by 2029, growing at a CAGR of 3.6% from 2023 to 2029. The market is mainly driven by the significant applications of Nebulizers and Inhalers in various end use industries. The expanding demands from the COPD, Cystic Fibrosis, Asthma and Others, are propelling Nebulizers and Inhalers market. Nebulizers, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Inhalers segment is estimated at % CAGR for the next seven-year period.
Global key manufacturers of Inhalers and Nebulizers include GSK, AstraZeneca, Chiesi, Boehringer Ingelheim, Teva, etc. Global top five manufacturers hold a share about 75%. North America is the largest market of Inhalers and Nebulizers, holds a share over 35%. In terms of product, the Inhalers holds a share of over 90%. And in terms of application, the largest application field is Asthma, with a share of over 45%.
Report Objectives
This report provides market insight on the different segments, by manufacturers, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Nebulizers and Inhalers, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Nebulizers and Inhalers market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Nebulizers and Inhalers market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Nebulizers and Inhalers sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Nebulizers and Inhalers covered in this report include PARI GmbH, Omron, Drive DeVilbiss Healthcare, Philips Respironics, Yuwell, Leyi, Folee, Medel S.p.A and Briggs Healthcare, etc.
The global Nebulizers and Inhalers market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
PARI GmbH
Omron
Drive DeVilbiss Healthcare
Philips Respironics
Yuwell
Leyi
Folee
Medel S.p.A
Briggs Healthcare
3A Health Care
Global Nebulizers and Inhalers market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Nebulizers and Inhalers market, Segment by Type:
Nebulizers
Inhalers
Global Nebulizers and Inhalers market, by Application
COPD
Cystic Fibrosis
Asthma
Others
Core Chapters
Chapter One: Introduces the study scope of this report, executive summary of market segments by Type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Two: Detailed analysis of Nebulizers and Inhalers manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Three: Sales, revenue of Nebulizers and Inhalers in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.
Chapter Four: Introduces market segments by Application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Five, Six, Seven, Eight and Nine: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.
Chapter Ten: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter Eleven: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics. Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Analysis of sales channel, distributors and customers.
Chapter Thirteen: Research Findings and Conclusion.
Inhalers and nebulizers are two different devices used to deliver quick-relief medicines (also called rescue or fast-acting medicines) or long-term control medicines (also called controller or maintenance medicines) directly into the lungs
The global Nebulizers and Inhalers market size is expected to reach US$ 18040 million by 2029, growing at a CAGR of 3.6% from 2023 to 2029. The market is mainly driven by the significant applications of Nebulizers and Inhalers in various end use industries. The expanding demands from the COPD, Cystic Fibrosis, Asthma and Others, are propelling Nebulizers and Inhalers market. Nebulizers, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Inhalers segment is estimated at % CAGR for the next seven-year period.
Global key manufacturers of Inhalers and Nebulizers include GSK, AstraZeneca, Chiesi, Boehringer Ingelheim, Teva, etc. Global top five manufacturers hold a share about 75%. North America is the largest market of Inhalers and Nebulizers, holds a share over 35%. In terms of product, the Inhalers holds a share of over 90%. And in terms of application, the largest application field is Asthma, with a share of over 45%.
Report Objectives
This report provides market insight on the different segments, by manufacturers, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Nebulizers and Inhalers, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Nebulizers and Inhalers market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Nebulizers and Inhalers market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Nebulizers and Inhalers sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Nebulizers and Inhalers covered in this report include PARI GmbH, Omron, Drive DeVilbiss Healthcare, Philips Respironics, Yuwell, Leyi, Folee, Medel S.p.A and Briggs Healthcare, etc.
The global Nebulizers and Inhalers market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
PARI GmbH
Omron
Drive DeVilbiss Healthcare
Philips Respironics
Yuwell
Leyi
Folee
Medel S.p.A
Briggs Healthcare
3A Health Care
Global Nebulizers and Inhalers market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Nebulizers and Inhalers market, Segment by Type:
Nebulizers
Inhalers
Global Nebulizers and Inhalers market, by Application
COPD
Cystic Fibrosis
Asthma
Others
Core Chapters
Chapter One: Introduces the study scope of this report, executive summary of market segments by Type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Two: Detailed analysis of Nebulizers and Inhalers manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Three: Sales, revenue of Nebulizers and Inhalers in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.
Chapter Four: Introduces market segments by Application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Five, Six, Seven, Eight and Nine: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.
Chapter Ten: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter Eleven: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics. Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Analysis of sales channel, distributors and customers.
Chapter Thirteen: Research Findings and Conclusion.
Index1 Nebulizers and Inhalers Market Overview
1.1 Nebulizers and Inhalers Product Overview
1.2 Nebulizers and Inhalers Market Segment by Type
1.2.1 Nebulizers
1.2.2 Inhalers
1.3 Global Nebulizers and Inhalers Market Size by Type
1.3.1 Global Nebulizers and Inhalers Market Size Overview by Type (2018-2029)
1.3.2 Global Nebulizers and Inhalers Historic Market Size Review by Type (2018-2023)
1.3.3 Global Nebulizers and Inhalers Forecasted Market Size by Type (2024-2029)
1.4 Key Regions Market Size Segment by Type
1.4.1 North America Nebulizers and Inhalers Sales Breakdown by Type (2018-2023)
1.4.2 Europe Nebulizers and Inhalers Sales Breakdown by Type (2018-2023)
1.4.3 Asia-Pacific Nebulizers and Inhalers Sales Breakdown by Type (2018-2023)
1.4.4 Latin America Nebulizers and Inhalers Sales Breakdown by Type (2018-2023)
1.4.5 Middle East and Africa Nebulizers and Inhalers Sales Breakdown by Type (2018-2023)
2 Global Nebulizers and Inhalers Market Competition by Company
2.1 Global Top Players by Nebulizers and Inhalers Sales (2018-2023)
2.2 Global Top Players by Nebulizers and Inhalers Revenue (2018-2023)
2.3 Global Top Players by Nebulizers and Inhalers Price (2018-2023)
2.4 Global Top Manufacturers Nebulizers and Inhalers Manufacturing Base Distribution, Sales Area, Product Type
2.5 Nebulizers and Inhalers Market Competitive Situation and Trends
2.5.1 Nebulizers and Inhalers Market Concentration Rate (2018-2023)
2.5.2 Global 5 and 10 Largest Manufacturers by Nebulizers and Inhalers Sales and Revenue in 2022
2.6 Global Top Manufacturers by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Nebulizers and Inhalers as of 2022)
2.7 Date of Key Manufacturers Enter into Nebulizers and Inhalers Market
2.8 Key Manufacturers Nebulizers and Inhalers Product Offered
2.9 Mergers & Acquisitions, Expansion
3 Nebulizers and Inhalers Status and Outlook by Region
3.1 Global Nebulizers and Inhalers Market Size and CAGR by Region: 2018 VS 2022 VS 2029
3.2 Global Nebulizers and Inhalers Historic Market Size by Region
3.2.1 Global Nebulizers and Inhalers Sales in Volume by Region (2018-2023)
3.2.2 Global Nebulizers and Inhalers Sales in Value by Region (2018-2023)
3.2.3 Global Nebulizers and Inhalers Sales (Volume & Value) Price and Gross Margin (2018-2023)
3.3 Global Nebulizers and Inhalers Forecasted Market Size by Region
3.3.1 Global Nebulizers and Inhalers Sales in Volume by Region (2024-2029)
3.3.2 Global Nebulizers and Inhalers Sales in Value by Region (2024-2029)
3.3.3 Global Nebulizers and Inhalers Sales (Volume & Value), Price and Gross Margin (2024-2029)
4 Global Nebulizers and Inhalers by Application
4.1 Nebulizers and Inhalers Market Segment by Application
4.1.1 COPD
4.1.2 Cystic Fibrosis
4.1.3 Asthma
4.1.4 Others
4.2 Global Nebulizers and Inhalers Market Size by Application
4.2.1 Global Nebulizers and Inhalers Market Size Overview by Application (2018-2029)
4.2.2 Global Nebulizers and Inhalers Historic Market Size Review by Application (2018-2023)
4.2.3 Global Nebulizers and Inhalers Forecasted Market Size by Application (2024-2029)
4.3 Key Regions Market Size Segment by Application
4.3.1 North America Nebulizers and Inhalers Sales Breakdown by Application (2018-2023)
4.3.2 Europe Nebulizers and Inhalers Sales Breakdown by Application (2018-2023)
4.3.3 Asia-Pacific Nebulizers and Inhalers Sales Breakdown by Application (2018-2023)
4.3.4 Latin America Nebulizers and Inhalers Sales Breakdown by Application (2018-2023)
4.3.5 Middle East and Africa Nebulizers and Inhalers Sales Breakdown by Application (2018-2023)
5 North America Nebulizers and Inhalers by Country
5.1 North America Nebulizers and Inhalers Historic Market Size by Country
5.1.1 North America Nebulizers and Inhalers Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
5.1.2 North America Nebulizers and Inhalers Sales in Volume by Country (2018-2023)
5.1.3 North America Nebulizers and Inhalers Sales in Value by Country (2018-2023)
5.2 North America Nebulizers and Inhalers Forecasted Market Size by Country
5.2.1 North America Nebulizers and Inhalers Sales in Volume by Country (2024-2029)
5.2.2 North America Nebulizers and Inhalers Sales in Value by Country (2024-2029)
6 Europe Nebulizers and Inhalers by Country
6.1 Europe Nebulizers and Inhalers Historic Market Size by Country
6.1.1 Europe Nebulizers and Inhalers Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
6.1.2 Europe Nebulizers and Inhalers Sales in Volume by Country (2018-2023)
6.1.3 Europe Nebulizers and Inhalers Sales in Value by Country (2018-2023)
6.2 Europe Nebulizers and Inhalers Forecasted Market Size by Country
6.2.1 Europe Nebulizers and Inhalers Sales in Volume by Country (2024-2029)
6.2.2 Europe Nebulizers and Inhalers Sales in Value by Country (2024-2029)
7 Asia-Pacific Nebulizers and Inhalers by Region
7.1 Asia-Pacific Nebulizers and Inhalers Historic Market Size by Region
7.1.1 Asia-Pacific Nebulizers and Inhalers Market Size Growth Rate (CAGR) by Region: 2018 VS 2022 VS 2029
7.1.2 Asia-Pacific Nebulizers and Inhalers Sales in Volume by Region (2018-2023)
7.1.3 Asia-Pacific Nebulizers and Inhalers Sales in Value by Region (2018-2023)
7.2 Asia-Pacific Nebulizers and Inhalers Forecasted Market Size by Region
7.2.1 Asia-Pacific Nebulizers and Inhalers Sales in Volume by Region (2024-2029)
7.2.2 Asia-Pacific Nebulizers and Inhalers Sales in Value by Region (2024-2029)
8 Latin America Nebulizers and Inhalers by Country
8.1 Latin America Nebulizers and Inhalers Historic Market Size by Country
8.1.1 Latin America Nebulizers and Inhalers Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
8.1.2 Latin America Nebulizers and Inhalers Sales in Volume by Country (2018-2023)
8.1.3 Latin America Nebulizers and Inhalers Sales in Value by Country (2018-2023)
8.2 Latin America Nebulizers and Inhalers Forecasted Market Size by Country
8.2.1 Latin America Nebulizers and Inhalers Sales in Volume by Country (2024-2029)
8.2.2 Latin America Nebulizers and Inhalers Sales in Value by Country (2024-2029)
9 Middle East and Africa Nebulizers and Inhalers by Country
9.1 Middle East and Africa Nebulizers and Inhalers Historic Market Size by Country
9.1.1 Middle East and Africa Nebulizers and Inhalers Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
9.1.2 Middle East and Africa Nebulizers and Inhalers Sales in Volume by Country (2018-2023)
9.1.3 Middle East and Africa Nebulizers and Inhalers Sales in Value by Country (2018-2023)
9.2 Middle East and Africa Nebulizers and Inhalers Forecasted Market Size by Country
9.2.1 Middle East and Africa Nebulizers and Inhalers Sales in Volume by Country (2024-2029)
9.2.2 Middle East and Africa Nebulizers and Inhalers Sales in Value by Country (2024-2029)
10 Company Profiles
10.1 PARI GmbH
10.1.1 PARI GmbH Company Information
10.1.2 PARI GmbH Introduction and Business Overview
10.1.3 PARI GmbH Nebulizers and Inhalers Sales, Revenue and Gross Margin (2018-2023)
10.1.4 PARI GmbH Nebulizers and Inhalers Products Offered
10.1.5 PARI GmbH Recent Development
10.2 Omron
10.2.1 Omron Company Information
10.2.2 Omron Introduction and Business Overview
10.2.3 Omron Nebulizers and Inhalers Sales, Revenue and Gross Margin (2018-2023)
10.2.4 Omron Nebulizers and Inhalers Products Offered
10.2.5 Omron Recent Development
10.3 Drive DeVilbiss Healthcare
10.3.1 Drive DeVilbiss Healthcare Company Information
10.3.2 Drive DeVilbiss Healthcare Introduction and Business Overview
10.3.3 Drive DeVilbiss Healthcare Nebulizers and Inhalers Sales, Revenue and Gross Margin (2018-2023)
10.3.4 Drive DeVilbiss Healthcare Nebulizers and Inhalers Products Offered
10.3.5 Drive DeVilbiss Healthcare Recent Development
10.4 Philips Respironics
10.4.1 Philips Respironics Company Information
10.4.2 Philips Respironics Introduction and Business Overview
10.4.3 Philips Respironics Nebulizers and Inhalers Sales, Revenue and Gross Margin (2018-2023)
10.4.4 Philips Respironics Nebulizers and Inhalers Products Offered
10.4.5 Philips Respironics Recent Development
10.5 Yuwell
10.5.1 Yuwell Company Information
10.5.2 Yuwell Introduction and Business Overview
10.5.3 Yuwell Nebulizers and Inhalers Sales, Revenue and Gross Margin (2018-2023)
10.5.4 Yuwell Nebulizers and Inhalers Products Offered
10.5.5 Yuwell Recent Development
10.6 Leyi
10.6.1 Leyi Company Information
10.6.2 Leyi Introduction and Business Overview
10.6.3 Leyi Nebulizers and Inhalers Sales, Revenue and Gross Margin (2018-2023)
10.6.4 Leyi Nebulizers and Inhalers Products Offered
10.6.5 Leyi Recent Development
10.7 Folee
10.7.1 Folee Company Information
10.7.2 Folee Introduction and Business Overview
10.7.3 Folee Nebulizers and Inhalers Sales, Revenue and Gross Margin (2018-2023)
10.7.4 Folee Nebulizers and Inhalers Products Offered
10.7.5 Folee Recent Development
10.8 Medel S.p.A
10.8.1 Medel S.p.A Company Information
10.8.2 Medel S.p.A Introduction and Business Overview
10.8.3 Medel S.p.A Nebulizers and Inhalers Sales, Revenue and Gross Margin (2018-2023)
10.8.4 Medel S.p.A Nebulizers and Inhalers Products Offered
10.8.5 Medel S.p.A Recent Development
10.9 Briggs Healthcare
10.9.1 Briggs Healthcare Company Information
10.9.2 Briggs Healthcare Introduction and Business Overview
10.9.3 Briggs Healthcare Nebulizers and Inhalers Sales, Revenue and Gross Margin (2018-2023)
10.9.4 Briggs Healthcare Nebulizers and Inhalers Products Offered
10.9.5 Briggs Healthcare Recent Development
10.10 3A Health Care
10.10.1 3A Health Care Company Information
10.10.2 3A Health Care Introduction and Business Overview
10.10.3 3A Health Care Nebulizers and Inhalers Sales, Revenue and Gross Margin (2018-2023)
10.10.4 3A Health Care Nebulizers and Inhalers Products Offered
10.10.5 3A Health Care Recent Development
11 Upstream, Opportunities, Challenges, Risks and Influences Factors Analysis
11.1 Nebulizers and Inhalers Key Raw Materials
11.1.1 Key Raw Materials
11.1.2 Key Raw Materials Price
11.1.3 Raw Materials Key Suppliers
11.2 Manufacturing Cost Structure
11.2.1 Raw Materials
11.2.2 Labor Cost
11.2.3 Manufacturing Expenses
11.3 Nebulizers and Inhalers Industrial Chain Analysis
11.4 Nebulizers and Inhalers Market Dynamics
11.4.1 Nebulizers and Inhalers Industry Trends
11.4.2 Nebulizers and Inhalers Market Drivers
11.4.3 Nebulizers and Inhalers Market Challenges
11.4.4 Nebulizers and Inhalers Market Restraints
12 Market Strategy Analysis, Distributors
12.1 Sales Channel
12.2 Nebulizers and Inhalers Distributors
12.3 Nebulizers and Inhalers Downstream Customers
13 Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.2 Data Source
14.2 Author Details
14.3 Disclaimer
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
